$12.39
À la fermeture: Nov 3 EDT
$12.39
0.000.00%
Pré-commercialisation: 4:00 PM EDT
L'intérêt à découvert sur Astria Therapeutics Inc (NASDAQ:ATXS) a augmenté lors de la dernière période de déclaration, augmentant de en hausse de 3.11M à 4.02M. Cela représente 8.98% des actions disponibles au public de l'entreprise.
L'intérêt à découvert pour Astria Therapeutics Corp (XNAS:ATXS) a diminué au cours de la dernière période de référence, passant de 280,30 M à 275,20 M. Cela a mis 1,17 % des actions de la société disponibles au public en position courte.
Sur la base du volume moyen récent de 4.72M actions échangées par jour, il faudrait 1 jour(s) aux détenteurs de cet intérêt à découvert pour clôturer leurs positions sans faire monter brusquement le cours de l'action.
Get Alert  | |||||||||
|---|---|---|---|---|---|---|---|---|---|
ATXS  | Astria Therapeutics, Inc. Comm  | 10/15/2025  | 10/24/2025  | 8.98%  | 44,804,757  | 4,024,158  | 4,715,677  | 1  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 09/30/2025  | 10/09/2025  | 6.93%  | 44,804,757  | 3,106,913  | 448,140  | 6.93  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 09/15/2025  | 09/24/2025  | 6.57%  | 44,804,757  | 2,941,993  | 396,141  | 7.43  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 08/29/2025  | 09/10/2025  | 6.22%  | 44,804,757  | 2,787,247  | 243,915  | 11.43  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 08/15/2025  | 08/26/2025  | 6.55%  | 44,804,757  | 2,936,502  | 281,903  | 10.42  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 07/31/2025  | 08/11/2025  | 6.52%  | 44,804,082  | 2,919,915  | 187,056  | 15.61  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 07/15/2025  | 07/24/2025  | 6.89%  | 44,804,082  | 3,086,484  | 300,333  | 10.28  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 06/30/2025  | 07/10/2025  | 7.12%  | 44,804,082  | 3,188,408  | 394,982  | 8.07  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 06/13/2025  | 06/25/2025  | 7.01%  | 44,804,082  | 3,142,998  | 361,593  | 8.69  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 05/30/2025  | 06/10/2025  | 6.73%  | 44,804,082  | 3,016,601  | 658,463  | 4.58  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 05/15/2025  | 05/27/2025  | 6.80%  | 44,804,082  | 3,047,285  | 610,498  | 4.99  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 04/30/2025  | 05/09/2025  | 6.25%  | 44,804,082  | 2,799,485  | 532,994  | 5.25  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 04/15/2025  | 04/25/2025  | 5.80%  | 54,350,952  | 3,152,273  | 422,960  | 7.45  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 03/31/2025  | 04/09/2025  | 5.26%  | 54,350,952  | 2,856,297  | 281,887  | 10.13  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 03/14/2025  | 03/25/2025  | 5.87%  | 54,350,952  | 3,192,096  | 293,563  | 10.87  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 02/28/2025  | 03/11/2025  | 5.86%  | 54,350,952  | 3,182,687  | 185,427  | 17.16  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 02/14/2025  | 02/26/2025  | 5.65%  | 54,350,952  | 3,071,172  | 235,814  | 13.02  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 01/31/2025  | 02/11/2025  | 5.53%  | 54,350,952  | 3,005,004  | 280,639  | 10.71  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 01/15/2025  | 01/27/2025  | 5.69%  | 54,350,952  | 3,094,988  | 336,414  | 9.2  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 12/31/2024  | 01/10/2025  | 6.19%  | 54,350,952  | 3,365,629  | 384,616  | 8.75  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 12/13/2024  | 12/24/2024  | 4.94%  | 54,350,952  | 2,684,828  | 406,007  | 6.61  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 11/29/2024  | 12/10/2024  | 5.79%  | 54,350,952  | 3,145,785  | 296,495  | 10.61  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 11/15/2024  | 11/26/2024  | 5.34%  | 54,350,952  | 2,900,709  | 224,290  | 12.93  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 10/31/2024  | 11/11/2024  | 6.52%  | 54,342,015  | 3,540,751  | 197,544  | 17.92  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 10/15/2024  | 10/24/2024  | 6.43%  | 54,342,015  | 3,494,164  | 263,430  | 13.26  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 09/30/2024  | 10/09/2024  | 6.38%  | 54,342,015  | 3,468,262  | 614,619  | 5.64  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 09/13/2024  | 09/24/2024  | 7.03%  | 54,342,015  | 3,818,084  | 249,538  | 15.3  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 08/30/2024  | 09/11/2024  | 7.39%  | 54,342,015  | 4,013,453  | 292,581  | 13.72  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 08/15/2024  | 08/26/2024  | 7.27%  | 54,342,015  | 3,949,570  | 321,463  | 12.29  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 07/31/2024  | 08/09/2024  | 6.79%  | 52,829,794  | 3,587,169  | 309,722  | 11.58  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 07/15/2024  | 07/24/2024  | 7.56%  | 52,829,794  | 3,995,802  | 513,805  | 7.78  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 06/28/2024  | 07/10/2024  | 8.03%  | 52,829,794  | 4,242,059  | 554,990  | 7.64  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 06/14/2024  | 06/26/2024  | 7.85%  | 52,829,794  | 4,145,571  | 421,398  | 9.84  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 05/31/2024  | 06/11/2024  | 7.50%  | 52,829,794  | 3,963,473  | 476,145  | 8.32  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 05/15/2024  | 05/24/2024  | 7.91%  | 52,829,794  | 4,178,754  | 739,875  | 5.65  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 04/30/2024  | 05/09/2024  | 8.67%  | 52,829,794  | 4,582,487  | 816,060  | 5.62  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 04/15/2024  | 04/24/2024  | 9.55%  | 52,829,794  | 5,046,064  | 829,478  | 6.08  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 03/28/2024  | 04/09/2024  | 9.87%  | 51,282,959  | 5,059,726  | 1,804,739  | 2.8  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 03/15/2024  | 03/26/2024  | 3.93%  | 51,282,959  | 2,012,943  | 1,277,118  | 1.58  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 02/29/2024  | 03/11/2024  | 3.31%  | 51,282,959  | 1,696,784  | 622,639  | 2.73  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 02/15/2024  | 02/27/2024  | 3.84%  | 51,045,910  | 1,962,115  | 702,957  | 2.79  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 01/31/2024  | 02/09/2024  | 4.01%  | 51,045,910  | 2,046,720  | 888,234  | 2.3  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 01/12/2024  | 01/24/2024  | 3.86%  | 37,414,695  | 1,443,054  | 771,235  | 1.87  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 12/29/2023  | 01/10/2024  | 3.95%  | 37,414,695  | 1,479,020  | 991,661  | 1.49  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 12/15/2023  | 12/27/2023  | 2.79%  | 32,676,089  | 912,787  | 544,482  | 1.68  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 11/30/2023  | 12/11/2023  | 2.53%  | 32,676,089  | 827,216  | 189,746  | 4.36  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 11/15/2023  | 11/27/2023  | 2.06%  | 32,676,089  | 672,596  | 203,250  | 3.31  | |
ATXS  | Astria Therapeutics, Inc. Comm  | 10/31/2023  | 11/09/2023  | 2.36%  | 32,674,506  | 772,750  | 322,732  | 2.39  | 
À la recherche des actions les plus vendues à découvert?